One Health Biosensing

Over $5B in exits from team creating Razorfish, One Drop, Big Foot, Welldoc, we're re-defining CGM

Print
Follow Claim My Business
Security Type
CAFES
Categories
Technology, Healthcare & Medical, Retail, Education
Min Investment
$100
Location
New York, , NY
No. Investors
135

Key Deal Facts

A multi-modal AI-enabled health sensing platform designed to revolutionize the $10bn CGM market
A low-cost, painless, needle-free solution for >1Bn people with diabetes, pre-diabetes and obesity
Proprietary silicon micro-needle array technology, 10 years in R&D, protected by >50 issued patents
Demonstrated performance in >1,500 hrs of onbody clinical data with an estimated MARD of <10
Bolstered by >60Bn data points and AI capabilities proven to reduce A1C by 1.9% and weight by >10lbs
Projecting $250M in revenue two years post launch and >$1bn five years post launch (not guaranteed)
Founder and CEO with a proven track record of
successful exits and a world class leadership team
Existing investors include RRE, Box Group, FJ Labs, True Ventures, First Round Capital, and others

Management Team / Advisory Board Bios

Jeff Dachis Founder and CEOA proven track record of successful entrepreneurship and disruptive innovation and over a decade of experience in digital design and the diabetes industry, Jon Brilliant CFOProven track record developing and launching diabetes devices, Dan Goldner EVP Research & DevelopmentProven expertise in data science, machine learning, and AI, Brian Kemper EVP Product & Programs15+ years in medical devices and digital solutions
Amount Raised : $201,466
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments